Cargando…
Circulating miR-221 Expression Level and Prognosis of Cutaneous Malignant Melanoma
BACKGROUND: The aim of this study was to investigate the feasibility of using serum miR-221 as a noninvasive prognostic biomarker for cutaneous malignant melanoma (CMM). MATERIAL/METHODS: We measured the expression levels of miR-221 in serum samples from 72 CMM patients and 54 healthy controls by re...
Autores principales: | Li, Ping, He, Quan-yong, Luo, Chen-qun, Qian, Li-yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259523/ https://www.ncbi.nlm.nih.gov/pubmed/25430553 http://dx.doi.org/10.12659/MSM.891327 |
Ejemplares similares
-
Expression of miR-221 and miR-489 in breast cancer patients and their relationship with prognosis
por: Li, Fanfan
Publicado: (2020) -
Plasma Levels of microRNA-221 (miR-221) are Increased in Patients with Acute Pulmonary Embolism
por: Liu, Tingwei, et al.
Publicado: (2018) -
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
por: Kawaguchi, T, et al.
Publicado: (2013) -
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
por: Zhang, Chun-Zhi, et al.
Publicado: (2010) -
Analysis on Value of Applying Serum miR-144 and miR-221 Levels in Diagnosing Atherosclerosis
por: Zhang, Jianxiu, et al.
Publicado: (2022)